Trusted Resources: People & Places
Online groups, photo galleries and blogs
Beverly L. Davidson, PhD
Raymond G. Perelman Center for
Cellular and Molecular Therapeutics
Children’s Hospital of Philadelphia
3401 Civic Center Blvd.
Philadelphia, Pennsylvania, United States
Beverly L. Davidson, PhD, is Director of the Raymond G. Perelman Center for Cellular and Molecular Therapeutics and Chief Scientific Strategy Officer at Children’s Hospital of Philadelphia, where she holds the Arthur V. Meigs Chair in Pediatrics. She is also a Professor in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine at the University of Pennsylvania and a Co-Founder of Spark Therapeutics, Inc., a biotechnology company CHOP created in 2013 to accelerate the timeline for bringing new gene therapies to market.
Beverly L. Davidson completed her PhD in Biological Chemistry, and Postdoctoral Fellowship from the University of Michigan, Ann Arbor, MI. Her research is focused on the development of novel therapies to treat inherited brain disorders. Dr. Davidson’s main research interest includes lysosomal storage diseases, mucopolysaccharidoses, spinal cerebellar ataxia, understanding how noncoding RNAs participate in neural development and neurodegenerative diseases processes, etc.
Sanfilippo Syndrome Type B: Analysis of Patients Diagnosed By the MPS Brazil NetworkMucopolysaccharidosis type IIIB is a rar...
Gene Therapy May Reverse Hurler Syndrome, a Rare and Severe Illness in KidsGene therapy might soon offer a new opti...
Music Therapy and Sanfilippo Syndrome: an Analysis of Psychological and Physiological Variables of Three Case Studie...Mucopolysaccharidosis type III (MPS III)...
Paul Harmatz, MDDr. Paul Harmatz is a Professor in Resid...
Heather Lau, MD, MSHeather Lau, M.D. M.S. is a board certif...
Europe Grants Orphan Drug Status to JR-441, ERT for Sanfilippo AThe European Commission has granted an o...
Long-Term Safety and Clinical Outcomes of Intrathecal Heparan-N-Sulfatase in Patients With Sanfilippo Syndrome Type ...Currently, there is no effective therapy...